The FibreGum Study - Changing the Course of Obesity in Children

Exclusion Criteria

• •Antibiotic administration in the last 6 months
• •Pre- or probiotic treatment in the last 6 weeks
• •Any professionally supervised treatment for weight management within the last year
• •Consumption of more than one nicotine product per month (e.g. cigarette, gum)
• •Adolescent females: any stages of known pregnancy or lactation period
• •Congenital disorder affecting the cardiovascular, hepatic or respiratory system in a relevant way (as per PI's or specialist's evaluation)
• •Malignant disease on treatment or previous tumour affecting the appetite system (e.g., suprasellar, hypothalamic tumours)
• •Systemic antibiotic or anti-inflammatory medication (e.g. systemic intake of glucocorticoids) over the last 7 days
• •Known eating disorder (medically diagnosed)
• •Participation in another investigation with an investigational drug within the 30 days preceding and during the present investigation
• •Dependency from the sponsor or the clinical investigator
• •Inability to follow the procedures of the investigation, e.g. due to language problems, psychological disorders, etc. of the participant and/or legal representative